2009 Drug Development Training Program:
Solutions to Drug Development Challenges Facing Early-Stage Biotechnology and Pharmaceutical Companies
Date: Sept 21 & 22, 2009
Hong Kong Science and Technology Park, Hong Kong, China
During this 2-day course, our experts will provide pragmatic and up-to-date advice to guide companies that are contemplating conducting clinical trials in the USA and Europe.
Who should attend?
- Decision-makers working in early-stage biotechnology and pharmaceutical companies
- Managers and scientists working for contract facilities involved in the manufacture of Phase I/II clinical supplies
- Technical personnel employed in analytical laboratories that support toxicology and clinical studies
- Entrepreneurs and founders of pharmaceutical and biotechnology companies who want to learn more about current issues in drug development
- Academic scientists and physicians who are considering setting up biotechnology or pharmaceutical companies
The program will be conducted in English.
- Overview of the Life Science Business in the U.S. and Europe
- U.S. and European Regulatory Strategies
- FDA Actions and Oversight in China
- GLP vs. GMP – What’s Right for Your Company?
- Early-Phase Clinical GMPs
- Preclinical and Analytical Development
- Supply Chain Management
- Gene and Cell Therapy Development and Regulation by FDA
- Technology Transfer and Intellectual Property
About Our Faculty
The faculty for this program has many years of experience conducting training programs in the USA and overseas, and includes a former US FDA Acting Division Director and international GMP compliance auditor, and drug development, regulatory affairs, quality assurance and manufacturing experts from the US and European pharmaceutical and biotechnology industry.
Our $550 USD registration fee includes networking lunches and printed course materials. Discounts are available for early registration, and to university faculty, full-time students and bioscience incubator companies affiliated with the HKSTP. Please email any questions to email@example.com.